Results for FAQs (107)

The maintenance medication policy requires pharmacists to dispense at least a 90-day supply for several maintenance drugs. Maintenance drugs are used to control and manage a variety of chronic or long

This highly effective program helps plan members currently taking one of the impacted originator biologic drugs to transition to the corresponding biosimilar product. This program applies in all

The Manitoba Exception Drug Status Program is a government sponsored program that provides coverage for certain drugs or devices provided the patient meets specific medical criteria. If you recently

The Exception Drug Status Program is a government sponsored program that provides coverage for certain drugs or devices provided the patient meets specific medical criteria. If you recently filled a

The “New Start” program lists biosimilars as preferred products under all formularies. Under this standard program, for all patients newly starting biologic therapy, the benefit plan covers only